Patent ID: 9549966
Date: 2017-01-24
CPC Classifications: A61B,A61K,A61P,G02B,G06T

Claim:
1. A method of treating a subject having dry eye syndrome, the method comprising: determining the number or average density of dendritic inflammatory cells present in the center of the cornea in an eye of the subject; comparing the number or average density of dendritic inflammatory cells present in the center of the cornea in the eye of the subject to a corresponding reference value; selectively administering to an eye(s) of a subject having dry eye syndrome, determined to have an elevated number or density of dendritic immune cells present in the center of the cornea as compared to the reference level, a topical steroid solution; selectively orally or topically administering to a subject having dry eye syndrome, determined to have an elevated number or density of dendritic immune cells present in the center of the cornea as compared to a reference level, two or more immunosuppressive agents; or selectively topically or orally administering to a subject determined to have an elevated number or elevated average density of dendritic inflammatory cells present in the peripheral cornea as compared to a corresponding reference value, at least one anti-inflammatory steroid and/or at least one immunosuppressive agent.